FOURTH AMENDMENT TO LETTER OF INTENTLetter Of • August 11th, 2006 • Quick Med Technologies Inc • Pharmaceutical preparations
It is hereby agreed as of June 30th, 2006 by and between Quick Med Technologies, Inc. (“Quick Med”) and Engelhard Long Island, Inc. (“Engelhard”) (collectively referred to as “the parties”) that:
LETTER OF INTENTLetter of Intent • August 11th, 2006 • Quick Med Technologies Inc • Pharmaceutical preparations
This Letter of Intent is effective this 1st day of February, 2006, by and between Englehard Long Island Inc. with a registered office at 50 Health Sciences Drive, Stony Brook, NY 11790 (“Licensee”) and Quick Med Technologies, Inc., with a registered office at 3427 SW 42nd Way, Gainesville, Florida 32608 (“Licensor”), relating to the possible licensing of Licensor’s proprietary matrix metalloproteinase inhibitor referred to as Ilomastat and defined as the “Licensed Compound” on Appendix A attached hereto (the “Term Sheet”). Certain capitalized terms not defined herein shall have the meanings ascribed to them in the Term Sheet.
FIRST AMENDMENT TO LETTER OF INTENTLetter Of • August 11th, 2006 • Quick Med Technologies Inc • Pharmaceutical preparations
It is hereby agreed as of April 26, 2006 by and between Quick Med Technologies, Inc. (“Quick Med”) and Engelhard Long Island, Inc. (“Engelhard”) (collectively referred to as “the parties”) that:
THIRD AMENDMENT TO LETTER OF INTENTLetter Of • August 11th, 2006 • Quick Med Technologies Inc • Pharmaceutical preparations
It is hereby agreed as of June 13, 2006 by and between Quick Med Technologies, Inc. (“Quick Med”) and Engelhard Long Island, Inc. (“Engelhard”) (collectively referred to as “the parties”) that:
SECOND AMENDMENT TO LETTER OF INTENTLetter Of • August 11th, 2006 • Quick Med Technologies Inc • Pharmaceutical preparations
It is hereby agreed as of May 26, 2006 by and between Quick Med Technologies, Inc. (“Quick Med”) and Engelhard Long Island, Inc. (“Engelhard”) (collectively referred to as “the parties”) that:
